Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2001) |
Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126 | Advances in Antiviral Drug Design | book series | 0.330 Q2 | 12 | 0 | 7 | 0 | 7 | 5 | 1.00 | 0.00 |  |
| 125 | Autonomic and Autacoid Pharmacology | journal | 0.376 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 124 | Chemical Speciation and Bioavailability | journal | 0.400 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 123 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q3 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | |
| 122 | Cytokines, Cellular and Molecular Therapy | journal | 0.549 Q2 | 28 | 0 | 84 | 0 | 127 | 84 | 1.16 | 0.00 | |
| 121 | Drugs in R and D | journal | 0.170 Q3 | 54 | 0 | 240 | 0 | 76 | 240 | 0.32 | 0.00 | |
| 120 | International Journal of Geriatric Psychopharmacology | journal | 0.411 Q1 | 11 | 0 | 75 | 0 | 102 | 71 | 0.41 | 0.00 | |
| 119 | Journal of Applied Therapeutic Research | journal | 0.117 Q4 | 8 | 0 | 51 | 0 | 3 | 51 | 0.04 | 0.00 | |
| 118 | Pharmacology and Toxicology, Supplement | journal | 0.179 Q3 | 7 | 0 | 47 | 0 | 16 | 46 | 0.27 | 0.00 | |
| 117 | Pharmacy and Pharmacology Communications | journal | 0.225 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 116 | Polymer Gels and Networks | journal | 0.671 Q1 | 30 | 0 | 43 | 0 | 45 | 43 | 0.00 | 0.00 | |
| 115 | Prescribers' Journal | journal | 0.161 Q3 | 6 | 0 | 110 | 0 | 24 | 80 | 0.30 | 0.00 | |
| 114 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.106 Q4 | 8 | 0 | 49 | 0 | 2 | 47 | 0.04 | 0.00 | |
| 113 | Toxic Substance Mechanisms | journal | 0.172 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 112 | Toxicology Methods | journal | 0.178 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 111 | Tumor Targeting | journal | 0.357 Q2 | 10 | 0 | 54 | 0 | 62 | 52 | 1.44 | 0.00 | |
| 110 | Drug Design and Discovery | journal | 0.350 Q3 | 20 | 1 | 66 | 0 | 55 | 62 | 0.83 | 0.00 | |
| 109 | BMC Chemical Biology | journal | 21 | 4 | 0 | 143 | 0 | 0 | 0.00 | 35.75 | | |
| 108 | BMC Clinical Pharmacology | journal | 43 | 4 | 0 | 98 | 0 | 0 | 0.00 | 24.50 | | |
| 107 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
| 106 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.952 Q1 | 69 | 10 | 100 | 431 | 342 | 88 | 3.42 | 43.10 | |
| 105 | Journal of Clinical Research | journal | 0.161 Q3 | 12 | 10 | 56 | 233 | 17 | 56 | 0.25 | 23.30 | |
| 104 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.898 Q1 | 99 | 10 | 35 | 1795 | 182 | 35 | 5.52 | 179.50 | |
| 103 | BMC Pharmacology | journal | 48 | 13 | 0 | 532 | 0 | 0 | 0.00 | 40.92 | | |
| 102 | Environmental Pollutants and Bioavailability | journal | 39 | 13 | 43 | 408 | 24 | 43 | 0.63 | 31.38 | | |
| 101 | European Journal of Herbal Medicine | journal | 3 | 14 | 0 | 321 | 0 | 0 | 0.00 | 22.93 | | |
| 100 | Toxin Reviews | journal | 0.348 Q3 | 54 | 15 | 90 | 859 | 63 | 87 | 0.81 | 57.27 | |
| 99 | British Journal of Clinical Pharmacology, Supplement | journal | 0.231 Q2 | 33 | 18 | 12 | 649 | 25 | 11 | 0.00 | 36.06 | |
| 98 | Paediatric and Perinatal Drug Therapy | journal | 0.183 Q3 | 20 | 18 | 38 | 381 | 15 | 34 | 0.41 | 21.17 | |
| 97 | DARU, Journal of Pharmaceutical Sciences | journal | 0.102 Q4 | 58 | 19 | 9 | 333 | 0 | 9 | 0.00 | 17.53 | |
| 96 | Mathematical Medicine and Biology | journal | 0.260 Q3 | 49 | 19 | 64 | 472 | 38 | 64 | 0.41 | 24.84 | |
| 95 | Comments on Toxicology | journal | 0.178 Q4 | 13 | 20 | 44 | 789 | 12 | 30 | 0.48 | 39.45 | |
| 94 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.275 Q3 | 25 | 21 | 54 | 738 | 52 | 28 | 0.93 | 35.14 | |
| 93 | Receptors and Channels | journal | 0.944 Q1 | 44 | 21 | 71 | 906 | 121 | 71 | 1.28 | 43.14 | |
| 92 | Toxicology Mechanisms and Methods | journal | 0.121 Q4 | 55 | 21 | 118 | 610 | 36 | 114 | 0.30 | 29.05 | |
| 91 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
| 90 | International Antiviral News | journal | 0.448 Q2 | 8 | 25 | 84 | 313 | 62 | 54 | 1.00 | 12.52 | |
| 89 | Pharmacy in Practice | journal | 0.119 Q4 | 6 | 25 | 70 | 141 | 5 | 40 | 0.08 | 5.64 | |
| 88 | Quality Assurance Journal | journal | 0.139 Q3 | 11 | 25 | 57 | 118 | 3 | 52 | 0.09 | 4.72 | |
| 87 | Pharmacology Reviews and Communications | journal | 0.165 Q3 | 9 | 26 | 43 | 777 | 15 | 43 | 0.24 | 29.88 | |
| 86 | Cutaneous and Ocular Toxicology | journal | 0.124 Q4 | 37 | 27 | 128 | 1630 | 17 | 109 | 0.10 | 60.37 | |
| 85 | Journal of Liposome Research | journal | 0.390 Q2 | 64 | 28 | 107 | 1003 | 110 | 88 | 1.01 | 35.82 | |
| 84 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 28 | 153 | 70 | 0 | 57 | 0.00 | 2.50 | |
| 83 | Drug Delivery | journal | 0.290 Q2 | 95 | 29 | 97 | 902 | 62 | 97 | 0.71 | 31.10 | |
| 82 | Natural Product Reports | journal | 2.341 Q1 | 211 | 34 | 115 | 7237 | 593 | 114 | 5.95 | 212.85 | |
| 81 | Journal of Autonomic Pharmacology | journal | 26 | 35 | 130 | 1075 | 92 | 130 | 0.69 | 30.71 | | |
| 80 | Toxicology and Industrial Health | journal | 0.806 Q1 | 69 | 35 | 152 | 1166 | 385 | 149 | 2.12 | 33.31 | |
| 79 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q2 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 | |
| 78 | Critical Reviews in Toxicology | journal | 2.297 Q1 | 129 | 36 | 38 | 2962 | 281 | 37 | 6.96 | 82.28 | |
| 77 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data